Skip navigation

8th Patient Reported Outcomes (PRO)

Generate, Analyze and Interpret PRO Data to Support Drug Development and Achieve Commercial Objectives

June 13-14, 2011
  • Philadelphia, Pennsylvania

Get In on Outcomes

Since the inaugural program in November of 2007, CBI’s Patient Reported Outcomes (PRO) franchise has evolved into a reliable, valuable and thought-provoking platform for the latest insights and best practices specific to PRO. This year’s agenda boasts fresh, new content and speakers from Pfizer, Endo, Johnson & Johnson, Novartis, Bayer Healthcare Pharmaceuticals, Mayo Clinic and Penn State Hershey College of Medicine.

Hear case studies and exciting examples of:

  • Drug Development Tool Qualification
  • Content Validity
  • PRO Label Claims
  • PRO in Children and Adolescents
  • ePRO in CNS

Plus, don’t miss our co-located event also taking place in Philadelphia on June 13-14, 2011, CBI’s Premier Health Economics and Outcomes Research (HEOR) Congress. Together, these events provide industry with a roadmap for using real world outcomes data to support regulatory approval and market access.